715 related articles for article (PubMed ID: 17306551)
41. Synthesis and cytotoxic activities of 2-alkyl-2,3-dihydro-1H-2,6,9-triazacyclopenta[b]anthracene-5,10-diones.
Kwak JH; Namgoong K; Jung JK; Cho J; Kim HM; Park SG; Yoo YA; Kwon JH; Lee H
Arch Pharm Res; 2008 Aug; 31(8):995-8. PubMed ID: 18787787
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.
El-Hawash SA; Wahab AE
Arch Pharm (Weinheim); 2006 Aug; 339(8):437-47. PubMed ID: 16881038
[TBL] [Abstract][Full Text] [Related]
43. Polysubstituted pyrazoles, part 6. Synthesis of some 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazol-3-carbonyl derivatives linked to nitrogenous heterocyclic ring systems as potential antitumor agents.
Rostom SA
Bioorg Med Chem; 2010 Apr; 18(7):2767-76. PubMed ID: 20207545
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety.
Havrylyuk D; Mosula L; Zimenkovsky B; Vasylenko O; Gzella A; Lesyk R
Eur J Med Chem; 2010 Nov; 45(11):5012-21. PubMed ID: 20810193
[TBL] [Abstract][Full Text] [Related]
45. Design, synthesis, and biological evaluation of novel N-γ-carboline arylsulfonamides as anticancer agents.
Chen J; Liu T; Wu R; Lou J; Cao J; Dong X; Yang B; He Q; Hu Y
Bioorg Med Chem; 2010 Dec; 18(24):8478-84. PubMed ID: 21067933
[TBL] [Abstract][Full Text] [Related]
46. Substituted quinazolines, part 2. Synthesis and in-vitro anticancer evaluation of new 2-substituted mercapto-3H-quinazoline analogs.
Khalil AA; Abdel-Hamide SG; Al-Obaid AM; El-Subbagh HI
Arch Pharm (Weinheim); 2003 Apr; 336(2):95-103. PubMed ID: 12761762
[TBL] [Abstract][Full Text] [Related]
47. New potential anticancer agents based on the anthranilic acid scaffold: synthesis and evaluation of biological activity.
Congiu C; Cocco MT; Lilliu V; Onnis V
J Med Chem; 2005 Dec; 48(26):8245-52. PubMed ID: 16366606
[TBL] [Abstract][Full Text] [Related]
48. 2-Mercapto-N-(azolyl)benzenesulphonamides. I. Synthesis of N-(1,1-dioxo-1,4,2-benzodithiazin-3-yl)guanidines and their transformations into 2-mercapto-N-(5-amino-1,2,4-triazol-3-yl) benzenesulphonamide derivatives with potential anti-HIV or anticancer activity.
Brzozowski Z
Acta Pol Pharm; 1995; 52(2):91-101. PubMed ID: 8960241
[TBL] [Abstract][Full Text] [Related]
49. Synthesis and antitumour evaluation of 4-bromophenyl semicarbazones.
Pandeya SN; Yogeeswari P; Sausville EA; Mauger AB; Narayanan VL
Arzneimittelforschung; 2002; 52(2):103-8. PubMed ID: 11878197
[TBL] [Abstract][Full Text] [Related]
50. Synthesis of novel 1,2,5-trisubstituted benzimidazoles as potential antitumor agents.
Abonia R; Cortés E; Insuasty B; Quiroga J; Nogueras M; Cobo J
Eur J Med Chem; 2011 Sep; 46(9):4062-70. PubMed ID: 21719162
[TBL] [Abstract][Full Text] [Related]
51. Synthesis of 1-(2,6-dichlorophenyl)-3-methylene-1,3-dihydro-indol-2-one derivatives and in vitro anticancer evaluation against SW620 colon cancer cell line.
Virsodia V; Manvar A; Upadhyay K; Loriya R; Karia D; Jaggi M; Singh A; Mukherjee R; Shaikh MS; Coutinho EC; Shah A
Eur J Med Chem; 2009 Mar; 44(3):1355-62. PubMed ID: 18316139
[TBL] [Abstract][Full Text] [Related]
52. Quinols as novel therapeutic agents. 2.(1) 4-(1-Arylsulfonylindol-2-yl)-4-hydroxycyclohexa-2,5-dien-1-ones and related agents as potent and selective antitumor agents.
Berry JM; Bradshaw TD; Fichtner I; Ren R; Schwalbe CH; Wells G; Chew EH; Stevens MF; Westwell AD
J Med Chem; 2005 Jan; 48(2):639-44. PubMed ID: 15658878
[TBL] [Abstract][Full Text] [Related]
53. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).
Caruso F; Rossi M; Tanski J; Pettinari C; Marchetti F
J Med Chem; 2003 Apr; 46(9):1737-42. PubMed ID: 12699391
[TBL] [Abstract][Full Text] [Related]
54. Dihydroxyxanthones prenylated derivatives: synthesis, structure elucidation, and growth inhibitory activity on human tumor cell lines with improvement of selectivity for MCF-7.
Castanheiro RA; Pinto MM; Silva AM; Cravo SM; Gales L; Damas AM; Nazareth N; Nascimento MS; Eaton G
Bioorg Med Chem; 2007 Sep; 15(18):6080-8. PubMed ID: 17614292
[TBL] [Abstract][Full Text] [Related]
55. Synthesis, crystal structure, cytotoxic and superoxide dismutase activities of copper(II) complexes of N-(4,5-dihydroimidazol-2-yl)azoles.
Saczewski F; Dziemidowicz-Borys E; Bednarski PJ; Gdaniec M
Arch Pharm (Weinheim); 2007 Jul; 340(7):333-8. PubMed ID: 17611942
[TBL] [Abstract][Full Text] [Related]
56. New 5-substituted thiazolo[3,2-b][1,2,4]triazol-6-ones: synthesis and anticancer evaluation.
Lesyk R; Vladzimirska O; Holota S; Zaprutko L; Gzella A
Eur J Med Chem; 2007 May; 42(5):641-8. PubMed ID: 17303290
[TBL] [Abstract][Full Text] [Related]
57. Synthesis of new oxathiazinane dioxides and their in vitro cancer cell growth inhibitory activity.
Borcard F; Baud M; Bello C; Dal Bello G; Grossi F; Pronzato P; Cea M; Nencioni A; Vogel P
Bioorg Med Chem Lett; 2010 Sep; 20(17):5353-6. PubMed ID: 20688516
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and antitumor activity of N-sulfonyl-3,7-dioxo-5β-cholan-24-amides, ursodeoxycholic acid derivatives.
Ren J; Wang Y; Wang J; Lin J; Wei K; Huang R
Steroids; 2013 Jan; 78(1):53-8. PubMed ID: 23127818
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and biological evaluation of imidazol-2-one derivatives as potential antitumor agents.
Xue N; Yang X; Wu R; Chen J; He Q; Yang B; Lu X; Hu Y
Bioorg Med Chem; 2008 Mar; 16(5):2550-7. PubMed ID: 18226907
[TBL] [Abstract][Full Text] [Related]
60. Semisynthesis and in vitro anticancer activities of andrographolide analogues.
Jada SR; Subur GS; Matthews C; Hamzah AS; Lajis NH; Saad MS; Stevens MF; Stanslas J
Phytochemistry; 2007 Mar; 68(6):904-12. PubMed ID: 17234223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
